Translating new insights of disease progression into treatment optimization in multiple sclerosisHILLERT, Jan; SOELBERG SØRENSEN, Per.Journal of neurology. 2008, Vol 255, issn 0340-5354, 84 p., SUP1Conference Proceedings

Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosisHUANG, Wen-Xin; PING HUANG; HILLERT, Jan et al.Multiple sclerosis. 2004, Vol 10, Num 5, pp 482-487, issn 1352-4585, 6 p.Article

Multiple sclerosis : Postlinkage geneticsHILLERT, Jan.Clinical neurology and neurosurgery. 2006, Vol 108, Num 3, pp 220-222, issn 0303-8467, 3 p.Conference Paper

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditionsHEMMINKI, Kari; XINJUN LI; SUNDQUIST, Jan et al.Neurogenetics (Oxford. Print). 2009, Vol 10, Num 1, pp 5-11, issn 1364-6745, 7 p.Article

Multiple sclerosis with and without CSF bands : Clinically indistinguishable but immunogenetically distinctIMRELL, Kerstin; LANDTBLOM, Anne-Marie; HILLERT, Jan et al.Neurology. 2006, Vol 67, Num 6, pp 1062-1064, issn 0028-3878, 3 p.Article

Smoking and multiple sclerosis susceptibilityHEDSTRÖM, Anna Karin; HILLERT, Jan; OLSSON, Tomas et al.European journal of epidemiology. 2013, Vol 28, Num 11, pp 867-874, issn 0393-2990, 8 p.Article

Rationale for early intervention with immunomodulatory treatmentsTINTORE, Mar.Journal of neurology. 2008, Vol 255, pp 37-43, issn 0340-5354, 7 p., SUP1Conference Paper

The search for a balance between short and long-term treatment outcomes in multiple sclerosisBAUMHACKL, Ulf.Journal of neurology. 2008, Vol 255, pp 75-83, issn 0340-5354, 9 p., SUP1Conference Paper

Confirmation of association between multiple sclerosis and CYP27B1SUNDQVIST, Emilie; BÄÄRNHIELM, Maria; ALFREDSSON, Lars et al.European journal of human genetics. 2010, Vol 18, Num 12, pp 1349-1352, issn 1018-4813, 4 p.Article

The biology of CNS remyelination : The key to therapeutic advancesFRANKLIN, Robin J. M; KOTTER, Mark R.Journal of neurology. 2008, Vol 255, pp 19-25, issn 0340-5354, 7 p., SUP1Conference Paper

The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcomeZIVADINOV, Robert; STOSIC, Milena; COX, Jennifer L et al.Journal of neurology. 2008, Vol 255, pp 61-74, issn 0340-5354, 14 p., SUP1Conference Paper

PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in SwedenKOSTULAS, Konstantinos; GRETARSDOTTIR, Solveig; HILLERT, Jan et al.Journal of the neurological sciences. 2007, Vol 263, Num 1-2, pp 113-117, issn 0022-510X, 5 p.Article

Evidence of linkage with HLA-DR in drb1^*15-negative families with multiple sclerosis : Canadian Collaborative Study GroupsLIGERS, Arturs; DYMENT, David A; WILLER, Cristen J et al.American journal of human genetics. 2001, Vol 69, Num 4, pp 900-903, issn 0002-9297Article

Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortOLSSON, Tomas; ACHIRON, Anat; HYLDGAARD JENSEN, Poul Erik et al.Multiple sclerosis. 2013, Vol 19, Num 11, pp 1533-1538, issn 1352-4585, 6 p.Article

High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based studyTINGHOG, Petter; HILLERT, Jan; KJELDGARD, Linnea et al.Multiple sclerosis. 2013, Vol 19, Num 14, pp 1923-1930, issn 1352-4585, 8 p.Article

Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practiceJUNGEDAL, Roger; LUNDKVIST, Malin; ENGDAHL, Elin et al.Multiple sclerosis. 2012, Vol 18, Num 12, pp 1775-1781, issn 1352-4585, 7 p.Article

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosisHOLMEN, Carolina; PIEHL, Fredrik; LYCKE, Jan et al.Multiple sclerosis. 2011, Vol 17, Num 6, pp 708-719, issn 1352-4585, 12 p.Article

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumabSØRENSEN, Soelberg; HYLDGAARD JENSEN, Poul Erik; GOLD, Ralf et al.Multiple sclerosis. 2011, Vol 17, Num 9, pp 1074-1078, issn 1352-4585, 5 p.Article

The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysmHELGADOTTIR, Anna; THORLEIFSSON, Gudmar; KYO, Yoshiki et al.Nature genetics. 2008, Vol 40, Num 2, pp 217-224, issn 1061-4036, 8 p.Article

Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairsOTURAI, Annette Bang; RYDER, Lars P; NYLAND, Harald et al.Multiple sclerosis. 2004, Vol 10, Num 1, pp 5-8, issn 1352-4585, 4 p.Article

Interplay between mechanisms of damage and repair in multiple sclerosisSTADELMANN, Christine; BRÜCK, Wolfgang.Journal of neurology. 2008, Vol 255, pp 12-18, issn 0340-5354, 7 p., SUP1Conference Paper

Gene expression profiling in cluster headache : A pilot microarray studySJOSTRAND, Christina; DUVEFELT, Kristina; STEINBERG, Anna et al.Headache. 2006, Vol 46, Num 10, pp 1518-1534, issn 0017-8748, 17 p.Article

Smokers run increased risk of developing anti-natalizumab antibodiesHEDSTRÖM, A. K; ALFREDSSON, L; RYNER, M. Lundkvist et al.Multiple sclerosis. 2014, Vol 20, Num 8, pp 1081-1085, issn 1352-4585, 5 p.Article

A genome-wide association study in progressive multiple sclerosisMARTINELLI-BONESCHI, Filippo; ESPOSITO, Federica; COLOMBO, Bruno et al.Multiple sclerosis. 2012, Vol 18, Num 10, pp 1384-1394, issn 1352-4585, 11 p.Article

Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: A PET study with the TSPO molecular imaging biomarker [¹¹C]vinpocetineGULYAS, Balazs; TOTH, Miklós; SCHAIN, Martin et al.Journal of the neurological sciences. 2012, Vol 320, Num 1-2, pp 110-117, issn 0022-510X, 8 p.Article